{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-309426","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2021-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.875679+00:00","generated_at":"2026-06-28T17:44:39.470835+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"HCA Healthcare EVP & Chief Clinical Officer appointment; Dr. Perlin to depart March 2022","bullets":["Dr. Jonathan B. Perlin will depart as President-Clinical Ops and CMO to become CEO of The Joint Commission, effective March 1, 2022.","Dr. Perlin remains in current role through Dec 31, 2021; transition period from Jan 1 to Feb 28, 2022.","Effective Jan 1, 2022, Dr. Michael S. Cuffe named Executive Vice President and Chief Clinical Officer.","Board approved the changes at October 21, 2021 meeting; orderly succession for a key clinical leadership role."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-309426","json":"https://secwatch.observer/filing/0001193125-21-309426.json","markdown":"https://secwatch.observer/filing/0001193125-21-309426.md","text":"https://secwatch.observer/filing/0001193125-21-309426.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312521309426/0001193125-21-309426-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312521309426/d222794d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T17:44:39.470835+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bb50772d11","claim":"Jonathan B. Perlin departed as President - Clinical Operations Group and Chief Medical Officer at HCA Healthcare, Inc..","evidence_excerpt":"Dr. Jonathan B. Perlin, President - Clinical Operations Group and Chief Medical Officer, notified HCA Healthcare, Inc. (the “Company”) on September 16, 2021 that he had accepted the role of president and CEO of The Joint Commission and will assume his new role on March 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312521309426/0001193125-21-309426-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"notified"},{"label":"Role","value":"President - Clinical Operations Group and Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"f5766594b2","claim":"Michael S. Cuffe was appointed as Executive Vice President and Chief Clinical Officer at HCA Healthcare, Inc..","evidence_excerpt":"effective January 1, 2022, Dr. Michael S. Cuffe will become Executive Vice President and Chief Clinical Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312521309426/0001193125-21-309426-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Clinical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}